Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Sell
50
GERN Quote, Financials, Valuation and Earnings
Last price:
$1.34
Seasonality move
:
17.7%
Day range:
$1.30 - $1.34
52-week range:
$1.04 - $3.68
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.83x
P/B ratio:
3.41x
Volume:
5.6M
Avg. volume:
7.6M
1-year change:
-60.18%
Market cap:
$849M
Revenue:
$77M
EPS (TTM):
-$0.12
Analysts' Opinion
-
Consensus RatingGeron Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 1 Hold rating, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $3.60, Geron Corp. has an estimated upside of 170.68% from its current price of $1.33.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1.00 representing 100% downside risk from its current price of $1.33.
Fair Value
-
According to the consensus of 5 analysts, Geron Corp. has 170.68% upside to fair value with a price target of $3.60 per share.
GERN vs. S&P 500
-
Over the past 5 trading days, Geron Corp. has underperformed the S&P 500 by -2.69% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Geron Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Geron Corp. has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Geron Corp. reported revenues of $47.2M.
Earnings Growth
-
Geron Corp. has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Geron Corp. reported earnings per share of -$0.03.
Enterprise value:
717.9M
EV / Invested capital:
1.44x
Price / LTM sales:
4.83x
EV / EBIT:
--
EV / Revenue:
3.91x
PEG ratio (5yr expected):
-3.96x
EV / Free cash flow:
-5.41x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$178.3M
Return On Assets:
-14.68%
Net Income Margin (TTM):
-43.61%
Return On Equity:
-29.65%
Return On Invested Capital:
-16.45%
Operating Margin:
-29.41%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $317K | $29.5M | $183.4M | $28.3M | $47.2M | |
| Gross Profit | -$602K | $27.9M | $178.3M | $27.6M | $45.9M | |
| Operating Income | -$181.6M | -$208M | -$63.1M | -$28.2M | -$13.9M | |
| EBITDA | -$180.6M | -$206.8M | -$61.8M | -$28M | -$13.6M | |
| Diluted EPS | -$0.34 | -$0.32 | -$0.12 | -$0.04 | -$0.03 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $179.4M | $222.1M | $335.1M | $398.1M | $522.3M | |
| Total Assets | $229.1M | $232.6M | $413M | $445M | $567.4M | |
| Current Liabilities | $38.5M | $82.8M | $89.4M | $137.9M | $87.7M | |
| Total Liabilities | $77.5M | $124.4M | $122.4M | $152.7M | $318.7M | |
| Total Equity | $151.6M | $108.2M | $290.6M | $292.3M | $248.7M | |
| Total Debt | $39.1M | $54.6M | $55.1M | $86.3M | $250.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$162M | -$215.6M | -$132.9M | -$58.9M | -$13.6M | |
| Cash From Investing | -$208.9M | $45.1M | -$17.4M | -$554K | $13.3M | |
| Cash From Financing | $340.7M | $201.5M | $168.1M | $3.6M | $542K | |
| Free Cash Flow | -$162.9M | -$216.5M | -$132.7M | -$58.9M | -$13.5M | |
GERN
Sector
Market Cap
$849M
$28.4M
Price % of 52-Week High
36.14%
51.17%
Dividend Yield
0%
0%
Shareholder Yield
-4.73%
-1.49%
1-Year Price Total Return
-60.18%
-16.67%
Beta (5-Year)
0.567
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$1.35
200-day SMA
Sell
Level
$1.36
Bollinger Bands (100)
Buy
Level
1.19 - 1.39
Chaikin Money Flow
Sell
Level
-1.1B
20-day SMA
Buy
Level
$1.29
Relative Strength Index (RSI14)
Buy
Level
55.59
ADX Line
Buy
Level
25.31
Williams %R
Neutral
Level
-50
50-day SMA
Buy
Level
$1.23
MACD (12, 26)
Buy
Level
0.04
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
713.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.0961)
Sell
CA Score
(Annual)
Level (-1.8313)
Sell
Beneish M-Score
(Annual)
Level (285.8367)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (1.9662)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.
Stock Forecast FAQ
In the current month, GERN has received 3 Buy ratings 1 Hold ratings, and 1 Sell ratings. The GERN average analyst price target in the past 3 months is $3.60.
-
Where Will Geron Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Geron Corp. share price will rise to $3.60 per share over the next 12 months.
-
What Do Analysts Say About Geron Corp.?
Analysts are divided on their view about Geron Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Geron Corp. is a Sell and believe this share price will drop from its current level to $1.00.
-
What Is Geron Corp.'s Price Target?
The price target for Geron Corp. over the next 1-year time period is forecast to be $3.60 according to 5 Wall Street analysts, 3 of them rate the stock a Buy, 1 rates the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is GERN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Geron Corp. is a Buy. 3 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of GERN?
You can purchase shares of Geron Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Geron Corp. shares.
-
What Is The Geron Corp. Share Price Today?
Geron Corp. was last trading at $1.34 per share. This represents the most recent stock quote for Geron Corp.. Yesterday, Geron Corp. closed at $1.33 per share.
-
How To Buy Geron Corp. Stock Online?
In order to purchase Geron Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get GERN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GERN
Sector
P/E ratio
--
23.89x
PEG ratio
-3.96x
-0.01x
P/B ratio
3.41x
1.81x
Price / LTM sales
4.83x
1.58x
Growth Metrics
GERN
Sector
Revenue growth
67.05%
4.62%
Earnings growth
30.83%
10.7%
Revenue (5-year growth)
178.45%
6.5%
Earnings forecast
-$0.04
-$0.21
Profitability
GERN
Sector
Profitability FY 2024
$75.7M
$3.6M
Return on invested capital
-16.45%
-31.84%
Return on assets
-14.68%
-27.96%
Return on equity
-29.65%
-37.63%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
25
Estimated Next Earnings Date
Feb
4
Balance Sheet
GERN
Sector
Total cash
$382.4M
$26.4M
Short term investments
$327.6M
$25.7M
Total assets
$594.5M
$76.9M
Long term debt
$250.3M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 23
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 23
UniFirst Corp. [UNF] is up 0.77% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
